Speakers

Learn from RBQM thought-leaders and benchmark your strategies for practical industry insights and take-home advice.

Mary Arnould

Director

Astellas Pharma

Christopher Biddle

Associate Director, Risk Management and Central Monitoring

Janssen Research

Jennifer Bournique

Associate Director, Risk Management & Central Monitoring

The Janssen Pharmaceutical Companies of Johnson & Johnson

Stephanie Clark

Director, Risk Management - Central Monitoring

The Janssen Pharmaceutical Companies of Johnson & Johnson

John (Jay) Daly

Clinical Study Risk Manager, Clinical Data Operations, Technology and Standards

UCB Biopharma

Laureen Dorschel

Clinical Data Manager

UCB Biopharma

Esther Huffman O'Keefe

Associate Director, Monitoring, Global Clinical Operations

Regeneron

Andy Lawton

Director

Risk-Based Approach Ltd

Ann Meeker O'Connell

Vice President, Integrated QMS/OMS

Vertex Pharmaceuticals

Amy Neubauer

Director, Data Quality Oversight

Alkermes Inc.

Rosanne Petros, PMP

Associate Director, Clinical Research

Merck Research Laboratories

Craig Reist, Ph.D.

VP & Chief Scientific Officer

2M Clinical

MaryAnne Rizk, Ph.D.

Senior Vice President, Digital R&D Strategy

IQVIA Technologies

Michael Walega

Head of Centralized Monitoring

Bristol Myers Squibb

Marion Wolfs

Head, Senior Director Risk Management & Central Monitoring

The Janssen Pharmaceutical Companies of Johnson & Johnson

Steve Young

Chief Scientific Officer

CluePoints